Loading data
CMRENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 877.9 m USD | 888.49 m USD | 848.29 m USD | 1.11 bn USD | 793.64 m USD |
| Operating profit | 456.19 m USD | 489.7 m USD | 594.97 m USD | 662.25 m USD | 441.35 m USD |
| Interest expense | 90.16 m USD | 117.07 m USD | 126.79 m USD | 107.21 m USD | 72.26 m USD |
| Net income (reported basis) | 364.58 m USD | 319.92 m USD | 385.75 m USD | 554.96 m USD | 435.12 m USD |
| Net income attributable to common shareholders | 343.66 m USD | 290.68 m USD | 354.68 m USD | 523.89 m USD | 404.05 m USD |
| Basic earnings per share | 2.86 USD/share | 2.44 USD/share | 2.95 USD/share | 4.26 USD/share | 3.28 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.